Methods for site-specific modification of proteins should be quantitative and versatile with respect to the nature and size of the biological or chemical targets involved. they should require minimal modification of the target, and the underlying reactions should be completed in a reasonable amount of time under physiological conditions. sortase-mediated transpeptidation reactions meet these criteria and are compatible with other labeling methods. Here we describe the expression and purification conditions for two sortase a enzymes that have different recognition sequences. We also provide a protocol that allows the functionalization of any given protein at its c terminus, or, for select proteins, at an internal site. the target protein is engineered with a sortaserecognition motif (lpXtG) at the place where modification is desired. upon recognition, sortase cleaves the protein between the threonine and glycine residues, facilitating the attachment of an exogenously added oligoglycine peptide modified with the functional group of choice (e.g., fluorophore, biotin, protein or lipid). expression and purification of sortase takes ~3 d, and sortase-mediated reactions take only a few minutes, but reaction times can be extended to increase yields. functions and therefore fewer substrates. In Staphylococcus aureus, proteins targeted to the bacterial surface have a conserved sortase-recognition motif, Leu-Pro-XxxThr-Gly (LPXTG, where X is any amino acid and glycine cannot be a free carboxylate), at or near the C terminus. Upon recognition, sortase A cleaves between the threonine and glycine residues to form an acyl-enzyme intermediate. The active-site cysteine of sortase A forms a bond with the carbonyl of the threonine residue of the target protein. This intermediate is then resolved by nucleophilic attack by the free amino group of the cell wall precursor lipid II. This lipid II-linked protein conjugate is incorporated during cell wall synthesis, and consequently the protein is displayed at the surface 24 (Fig. 1) .
IntroDuctIon
One of the goals of protein engineering is the installation of desirable features, template-encoded or otherwise, on proteins that naturally lack them. The ability to confer different functionalities onto a protein of interest enables a broad array of applications. Attachment of a fluorophore to a protein allows for its use in live-cell microscopy, whereas generation of a fusion between an antibody and a payload of interest, such as a toxin or an antigen, can find use in therapeutics and vaccine development, respectively [1] [2] [3] [4] .
Several strategies based on genetic, chemical, enzymatic or chemo-enzymatic methods equip proteins with functional groups. Genetic engineering is the method of choice when modification at a precise site is required. However, the effect of the genetically appended sequence on expression, folding and function of the final product is difficult to predict. Some proteins are simply refractory to the construction of functional fusions by standard genetic means 1 . The range of modifications that can be applied to a protein as a fusion product is limited in the first instance to those that are template-encoded.
Chemical modifications of proteins are more versatile but lack precision, as they usually target exposed cysteine or lysine residues. Moreover, because the reactions often call for nonphysiological reaction conditions (with respect to pH, reducing conditions and ionic composition), chemical damage of the target protein can occur. Proteins can be selectively labeled at their C terminus using the expressed protein ligation method, but generation of the required thioester from the protein-intein fusion is, in many cases, a low-yield process 5 . Only recently has this issue been addressed 6 .
Enzymatic methods can also overcome some of the drawbacks observed during chemical labeling, and they afford site-specific protein modification. However, these methods often require the following: genetic installation of sizable catalytically active protein domains (such as the O 6 -alkylguanine-DNA alkyltransferases (SNAP-or CLIP-based technology 7, 8 ) and haloalkane dehalogenases (HaloTag technology, 20-40 kDa; ref. 9)) onto the protein substrate; installation of the 15-aa BirA acceptor peptide 10 , the use of which is limited to biotin and its synthetically demanding chemical derivatives; engineering of a 13-aa acceptor peptide for lipoic acid ligase 11 , with the limitation that it primarily accepts lipid substrates and therefore mutant screens are required to incorporate new functionalities; the use of the formylglycine-generating enzyme that converts a cysteine residue within the context of a LCTPSR sequence (aldehyde tag) into formylglycine that can be used in oxime ligations 12, 13 ; or exploitation of the enzyme phosphopantotheinyltransferase to conjugate CoA-derived molecules to a specific 11-aa sequence 14 .
Sortase-mediated transpeptidation reactions are a versatile complement to these protein modification strategies [15] [16] [17] [18] , and they predominantly rely on the use of modified peptides, readily accessible by solid-phase peptide synthesis using commercially available building blocks. Besides labeling of the protein of interest at its C terminus or at an internal region as described here, sortases allow functionalization of the N terminus 19 and creation of non-natural fusions (i.e., N-N or C-C chimeras) via the installation of click handles 20 . By using sortases, we achieve labeling with similar precision to that afforded by genetic fusions, and we also provide ready access to protein derivatives and structures that are unattainable genetically.
Sortases and mechanism of action
Gram-positive bacteria display proteins at their surface to enable them to acquire nutrients, evade host immunity or adhere to sites of infection 21 . Sortases comprise a family of membrane-associated transpeptidases that anchor those proteins to the cell wall 17, 22 . The different members of the sortase family can be divided into four subfamilies, on the basis of their distinct primary sequences and substrates 23 . Although sortases of type A accept a large number of protein substrates, sortases of types B-D have more specialized
Site-specific C-terminal and internal loop labeling of proteins using sortase-mediated reactions functions and therefore fewer substrates. In Staphylococcus aureus, proteins targeted to the bacterial surface have a conserved sortase-recognition motif, Leu-Pro-XxxThr-Gly (LPXTG, where X is any amino acid and glycine cannot be a free carboxylate), at or near the C terminus. Upon recognition, sortase A cleaves between the threonine and glycine residues to form an acyl-enzyme intermediate. The active-site cysteine of sortase A forms a bond with the carbonyl of the threonine residue of the target protein. This intermediate is then resolved by nucleophilic attack by the free amino group of the cell wall precursor lipid II. This lipid II-linked protein conjugate is incorporated during cell wall synthesis, and consequently the protein is displayed at the surface 24 (Fig. 1) .
Diversity of applications
Sortase-mediated reactions are applicable to any protein of interest, provided it contains an LPXTG motif as the sortase target or a suitably exposed glycine residue to serve as the incoming nucleophile. Both modifications (LPXTG, glycine) can be introduced using standard molecular cloning protocols. In addition, sortases A are easily expressed in soluble recombinant form and in excellent yield in Escherichia coli. The natural nucleophile, lipid II, can be replaced by any peptide with an oligoglycine (Gly 1−5 ) at the N terminus (in many cases a single glycine suffices). In turn, the peptides can be decorated with any molecule accessible through chemical synthesis (e.g., fluorophores, biotin, crosslinkers, lipids, carbohydrates, nucleic acids) 1, 16, 17, [25] [26] [27] [28] [29] , provided that a free N-terminal glycine remains available on the peptide used as the incoming nucleophile. Thus, incubation of sortase, LPXTG-containing protein and nucleophile leads to the covalent attachment of that nucleophile to the protein of interest in a sitespecific manner. Because the oligoglycine peptide that serves as the nucleophile is functionalized beforehand, the chemical reaction conditions used to incorporate the functional group damage neither the sortase nor the protein substrate as long as the modified oligoglycine peptide remains in solution once it is added to the sortase reaction. Proteins can also serve as nucleophiles, provided they display a suitably exposed (stretch of) glycine(s) at their N terminus (Gly 1−5 ). Although in many cases one glycine is enough, we recommend installing more glycines, especially in those nucleophiles predicted to have a poorly exposed N terminus. The presence of even a single additional glycine can markedly change the efficiency of the reaction 30 . Such a modification allows the proteins to be N-terminally labeled with functionalized peptides 30, 31 or to form protein-protein adducts 1, 4, 32 .
By relying on a common mechanistic principle, sortagging affords ready access to a wealth of site-specific modifications: C-terminal 16, 25, 33 , internal loop regions 1, 34 , N-terminal 30, 31 and formation of cyclized (poly)peptides 30, 35, 36 . We have mainly used sortases of type A derived from S. aureus and Streptococcus pyogenes. Versions of S. aureus with improved K cat values 37 , as well as mutant versions that do not require Ca 2+ ions 38 , have been reported, and they further extend the range of reaction conditions and applications. S. pyogenes sortase A accepts dialanine (poly)peptides as nucleophiles 39 . The possibility of using two orthogonal sortases increases the versatility of these labeling reactions, as one can attach two different labels to one and the same molecule of choice 40 .
Limitations
More than 50 different substrates including peptides 28, 35 , soluble proteins 16, 30, 33, 34 , membrane proteins displayed at the cell surface 16, 41 , M13 bacteriophage 42 , budding influenza virus 3 , antibodies 4, 29, 32 , bacterial toxins 1, 40 and preassembled complexes 1, 40 have yielded to sortase labeling. Although we have yet to encounter a protein that could not be labeled using sortase, a parameter that critically influences the efficiency of the labeling reaction is the flexibility and accessibility of the region to be labeled. In most cases, this issue can be circumvented, yet to some extent the intrinsic structure of the substrate protein will impose limitations. This is true in particular when labeling an internal region of the protein, as some loop regions may not tolerate any type of genetic engineering.
One initial limitation of using sortase A from S. aureus was its obligate Ca 2+ -dependent activity 16 . The presence of calcium in the reaction buffer precludes the use of phosphate-based buffers. Sortase A from S. pyogenes 39 or from a mutant form of S. aureus (E105K/E108A (ref. 38)) is Ca 2+ independent and thus circumvents this limitation.
Not every laboratory is equipped to perform peptide synthesis, and commercial vendors provide such services. To assist those interested in synthesizing their own peptides, we have included protocols that describe the synthesis of probes of general utility (biotin and fluorophores). It requires minimal specialized equipment (reaction vessels for peptide synthesis) and involves reactions readily executed in a laboratory outfitted for biochemical work (fume hoods, appropriate organic waste disposal and a lyophilizer).
Advantages of the method
Sortase-mediated reactions are site-specific; afford high labeling yields; are versatile with respect to the moieties to be attached to the protein of interest (biotin 1, 16 peptides 1 , sugars 27 , lipids 25 and so on); are flexible regarding the labeling position on a protein: N, C, both N and C terminus, and solvent-accessible loops; enable the cyclization of proteins or peptides, if N and C termini are in close proximity; can be carried out under physiological conditions; require minimal modification of the target protein (5-amino acid recognition sequence); can be orthogonal, as sortases recognizing different motives are available; and can be performed using sortase A in solution or sortase A immobilized on a solid support 43 .
Experimental design
The components of any sortagging reaction are: sortase, substrate and nucleophile. 44 , but their molecular weight is different. This is a useful trait to explore in those cases where the molecular weights of the protein to be labeled and of the sortase to be used are similar. In addition, we equipped the ∆59 truncated version with a thrombin cleavage site that releases the His 6 tag upon digestion. This not only facilitates further downstream purification but also increases the mobility of sortase in SDS-PAGE gels, allowing a clear-cut distinction between sortase and substrate if required. The same protocol can be used to express and purify the various sortases. Sortase A is expressed in E. coli as a His 6 fusion to facilitate purification using a nickel-chelate affinity column. The described standard procedure yields ~40 mg l −1 S. aureus sortase A, 25 mg l −1 Ca 2+ -independent S. aureus sortase A and 30 mg l −1 S. pyogenes sortase A in good purity. The protein also remains soluble when it is concentrated.
Engineering substrates for C-terminal labeling. Substrates equipped with the LPXTG-recognition motif for S. aureus, or LPXTA for S. pyogenes, can be engineered using standard molecular cloning protocols. Although any amino acid can precede the threonine residue, a glutamic acid is often used because it is commonly found in the natural sortase A substrates 45 . The sortaserecognition sequence is usually engineered at the C terminus of the protein to be modified, with the G or A residue in amide linkage, followed by an affinity purification handle (e.g., His 6 ) that is lost upon reaction (Fig. 2) . The efficiency of the sortase-mediated reaction depends on the flexibility and accessibility of the region comprising the sortase A-recognition motif. Thus, if the C terminus of the protein is known to be hidden (in the absence of a known structure, a failure to yield to sortase labeling would be a clear indication of lack of accessibility), we recommend engineering a flexible linker composed of (Gly 4 Ser) n preceding the LPXTG/A sequence. The length of such linkers needs to be tested empirically for each protein of interest. If the amino acid immediately following the initial methionine is a glycine or alanine residue, you should consider deleting the amino acid or mutating it (to serine, for example). Having an LPXTG/A-recognition sequence at the C terminus and glycine/alanine at the N terminus of the same protein substrate may result in cyclization or polymerization of the protein as a competing side reaction during labeling 30 .
Engineering substrates for internal loop labeling. Site-specific modification of an internal solvent-exposed region in the protein of interest is a particular case of C-terminal labeling. As long as the LPXTG/A motif is introduced in an unstructured segment of the substrate protein, sortase can recognize the sequence 34 . An LPXTG motif that is highly structured is usually a poor sortase substrate 1, 34 . Flexibility can be ensured through installation of a specific protease cleavage site, immediately downstream of the sortase motif 1 . Upon cleavage, the newly exposed C terminus including the LPXTG/A motif is likely to be unstructured. Depending on the sequence of the protein, we rely on established site-directed mutagenesis strategies to insert an LPXTG/A motif at the intended site. As sortase cleaves the protein at the site of recognition, it is likely that the two halves of the protein will separate upon sortagging unless otherwise stabilized, for example, through a disulfide bond 1 or for topological reasons 34 . Thus, selecting an internal location for a sortase site in a loop region constrained by a disulfide bond might minimize the risk of such disintegration (Fig. 3) . Note that the protease to use must be tested empirically to ensure that the protease does not cleave elsewhere within the protein. Trypsin and Factor Xa are examples of proteases used for this purpose 1 .
Peptide synthesis. Here we describe the manual synthesis of several peptides that can be used in reactions mediated by sortase A from S. aureus, and therefore contain glycine residues at the N terminus. For reactions using sortase A from S. pyogenes, an alaninebased peptide is used as a nucleophile. Their synthesis follows the same protocol, except for the use of Fmoc-Ala-OH in place of Fmoc-Gly-OH. Perform two or three repeated couplings of FmocAla-OH to obtain the di-and tri-alanine sequences, respectively. In addition, Fmoc-Lys(biotin)-OH, Fmoc-Lys(5-TAMRA)-OH and other conjugates can be purchased as premade building blocks. These building blocks are more expensive, but they reduce the time required for synthesis and facilitate purification of the desired final product.
Purification of the substrate-labeled product. Because the protein substrate is constructed with a His 6 handle downstream of the LPXTG/A motif, the protein substrate molecules that were not labeled will retain the His 6 tag upon reaction. The sortases are themselves tagged with His 6 . Thus, a convenient strategy to separate the labeled product from sortase and unreacted substrate is the use of affinity chromatography (Nickelnitrilotriacetic acid (Ni-NTA) beads), followed by fast protein liquid chromatography (FLPC) or by a desalting column to remove the unreacted peptide nucleophile. Be sure to check compatibility of the incorporated functionality with Ni-NTA purification. We have noted that some functional groups, including acylhydrazones, bind to the resin.
Figure 3 | Labeling an internal loop of a protein. A protein comprising a loop formed by the establishment of a disulfide bond is modified to contain the sortase-recognition motif (LPXTG), followed by a specific protease cleavage site. To increase flexibility of the LPXTG-containing region, the loop is nicked with the protease of choice, and the sortase-mediated reaction follows as described for C-terminal labeling. Note that as long as the region containing the LPXTG motif is flexible and accessible, a proteolytic event may not be required. The presence of a disulfide bridge is also not crucial for the reaction. Although such a bond is convenient to ensure that the protein will not disintegrate upon labeling, at times the topology and conformation of the protein of interest naturally ensures integrity. • The cleavage cocktail should be freshly prepared for each experiment. LB medium Autoclave the medium. Store it at 4 °C for up to 6 months. Add the desired antibiotic just before using the medium. LB medium agar plates Prepare LB medium according to instructions. Autoclave the medium, allow it to cool down, and then add the desired antibiotic. Pour the medium into plates and store it at 4 °C for up to 3 months.
MaterIals

REAGENTS
Kanamycin Prepare kanamycin at a concentration of 30 mg ml −1 in water and filter-sterilize it.  crItIcal Store it at −20 °C (1,000× stock) for up to 6 months. Ampicillin, sodium salt Prepare ampicillin at a concentration of 100 mg ml −1 in water and filter-sterilize it.  crItIcal Store it at −20 °C (1,000× stock) for up to 6 months.
Isopropyl-b-d-thiogalactopyranoside
Prepare isopropyl-β-d-thiogalactopyranoside at a concentration of 0.5 M in water.  crItIcal Store it at −20 °C (1,000× stock) for up to 1 month. proceDure peptide synthesis 1| There are three options for synthesizing the peptides. Note that in all three options NMP may be replaced with DMF. Option A describes the procedure for the preparation of GGGK-biotin and GGGK-TAMRA peptides. In-solution coupling of N-hydroxysuccinimide (NHS) esters to (partially) protected peptides provides a route to couple base/acid-labile and/or more costly dyes (such as Alexa Fluor 647) or other suitable precursors to a GGG-containing peptide (GGGK-NHS ester, option B). An alternative for the installation of chemical groups of interest onto a peptide is to use a cysteine-maleimide reaction (option C). The procedure for option C is similar to that for the GGGK-NHS ester peptide, except that the lysine is replaced by a cysteine and a maleimide-derived dye or probe is substituted for the NHS ester. Under appropriate conditions, the maleimide will react with the cysteine exclusively, and therefore fully deprotected peptides can be used in option C.
(a) GGGK-biotin and GGGK-taMra peptides • tIMInG 2-3 d (i) Resin preparation (15 min).
Add 100 µmol of Rink amide resin (167 mg, 0.6 mmol g −1 ) into a capped glass column with a fritted glass bottom, solvate the resin in DCM (7 ml) by shaking it for 15 min in a wrist-action shaker at RT and remove the DCM by vacuum filtration. (ii) Deprotection and washing (30 min). Add 20% (vol/vol) piperidine solution in NMP (7 ml) and shake it for 15 min at RT to remove the resin's Fmoc-protecting groups. (iii) Remove the piperidine solution by vacuum filtration and wash the resin three times with NMP (7 ml, 1 min), three times with DCM (7 ml, 1 min) and an additional time with NMP (7 ml, 1
min). (iv) Coupling reactions and washing (2-3 h per coupling until Pause Point, 3.5 h total). Dissolve Fmoc-Lys(Mtt)-OH
(188 mg, 300 µmol), HBTU (114 mg, 300 µmol) and DIPEA (104 µl, 600 µmol) in NMP (7 ml) and add it to the resin. Shake the suspension for 2 h at RT. (v) Remove the reaction solution by vacuum filtration and wash the resin three times with NMP (7 ml, 1 min) and three times with DCM (7 ml, 1 min). Confirm the coupling reaction by performing a Kaiser test or a microcleavage test (Box 1).  crItIcal step If the reaction is incomplete, repeat
Step 1A(iv,v) with half the amount of reagents used for a standard coupling and shake it for 1 h at RT.  crItIcal step Only store protected peptides. 
Box 1 | Monitoring of peptide coupling • tIMInG variable; <1 h aDDItIonal MaterIals
• Ninhydrin (Eastman, cat. no. 2495) ! cautIon Ninhydrin is harmful.
• Potassium cyanide (Sigma-Aldrich, cat. no. 31252) ! cautIon Potassium cyanide is highly toxic.
• Phenol (J.T. Baker, cat. no. 2858-04) ! cautIon Phenol is toxic and corrosive.
• Piperidine (Sigma-Aldrich, cat. no. 104094) ! cautIon Piperidine is flammable and corrosive.
• Pyridine (Sigma-Aldrich, cat. no. 360570) ! cautIon Pyridine is highly flammable and toxic.
• TFA (Sigma-Aldrich, cat. no. T6508) ! cautIon TFA is strongly corrosive and toxic.
• 46 . This test works on primary amines and does not work for testing the attachment of an amino acid to a proline residue. Alternative methods such as the acetaldehyde/p-chloranil test or microcleavage test (option B) must be used to monitor these reactions 47, 48 . (vii) Wash the resin three times with NMP (7 ml, 1 min), three times with DCM (7 ml, 1 min), and then once briefly with NMP (7 ml, 1 min) containing DIPEA (500 µmol, 5 equiv.).  crItIcal step This final wash step neutralizes the resin and improves the coupling efficiency in the next step. This wash step should be brief. Prolonged exposure to alkaline conditions may result in partial removal of the Fmocprotecting group. (viii) To synthesize the biotin-containing probe, make a solution of biotin (74 mg, 300 µmol), HBTU (114 mg, 300 µmol) and DIPEA (104 µl, 600 µmol) in NMP (7 ml). Add the solution to the resin and shake it for 2 h at RT. The reaction product consists of the G 3 K-biotin peptide. To synthesize the TAMRA-containing probe, prepare a solution of 5(6)-TAMRA (52 mg, 120 µmol), PyBOP (63 mg, 120 µmol) and DIPEA (42 µl, 240 µmol) in NMP (7 ml and centrifuge it at 16,000g for 10 min at RT. Up to 50% of tert-Butanol may be added to peptides that do not readily dissolve in pure water. (xvii) Purify the centrifuged supernatant by reverse-phase HPLC on a C18 column using a 10-70% water-acetonitrile gradient over 15 min with 0.1% (vol/vol) TFA, followed by flushing at 90% (vol/vol) acetonitrile for 5 min. We recommend starting with a small 100-µl injection and adjusting the gradient accordingly for peptide purity and ease of separation. Once a good gradient is established, we recommend purifying the rest of the crude material with 400-600-µl injections. (xviii) Analyze the fractions for the presence of the desired product by LC/MS (Step 1A(xv)), and lyophilize the desired fractions to dryness.  crItIcal step TAMRA-containing probes consist of a mixture of regioisomers, which are easily separated by reverse-phase HPLC. Both regioisomers can be used in sortase A-catalyzed transacylation reactions.  pause poInt The lyophilized peptide can be stored at −20 °C indefinitely.
(B) GGGK-nHs ester probes • tIMInG 3 d (i) Follow
Step 1A(ii-v) but by using Fmoc-Lys(Boc)-OH (141 mg, 300 µmol) instead of the Mtt-protected lysine.
(ii) Follow
Step 1A(ii-v) by substituting Fmoc-Gly 3 -OH (123 mg, 300 µmol) for the lysine residue.
(iii) Cleave and precipitate the peptide from the resin with the Fmoc group still on the terminal glycine, as described in
Step 1A(xii-xv).  crItIcal step It is crucial to leave the Fmoc-protecting group on the peptide, as it prevents unwanted side reactions during the NHS ester coupling.  crItIcal step Hydrophobic peptides may precipitate poorly. Dry the supernatant of the ether precipitation by rotary evaporation to increase the yield.  pause poInt Store the crude peptide at −20 °C for up to 1 month. If it is lyophilized, store it at −20 °C indefinitely. (iv) Purify the peptide by reverse-phase HPLC as indicated in Step 1A(xvi,xvii) . If LC/MS shows that the crude peptide is of sufficient purity, this HPLC purification may be omitted. tert-Butanol may be added to peptides that do not dissolve in pure H 2 O before HPLC purification. (v) NHS ester coupling. Dissolve the peptide in DMSO. (vi) Add three to five equivalents of the Fmoc-GGGK peptide in DMSO to the NHS ester and add five equivalents of DIPEA.
(vii) Incubate the reaction for 16 h at RT. To prevent photobleaching or photoconversions, exclude the peptide from light by covering its containers in aluminum foil.  crItIcal step It is important to leave the reaction for 16 h. Although the coupling of the NHS ester may be faster, the added DIPEA also facilitates (slow) removal of the Fmoc-protecting group. (viii) Acidify the reaction mixture with 0.1% (vol/vol) aqueous TFA and purify the peptide by reverse-phase HPLC, as described in Step 1A(xvi-xviii).  pause poInt The crude product should be purified as soon as possible, but it can be stored as a solid at −20 °C for a week before purification. The pure peptide can be stored at −20 °C indefinitely. 3| Start overnight culture. Inoculate an individual colony from the plate into 100 ml of LB-ampicillin or LB-kanamycin medium (depending on the construct) and shake it at 220 r.p.m. at 37 °C overnight.  crItIcal step Use freshly transformed plates to ensure optimal expression.
4| Start expression culture. Dilute 10 ml of the overnight culture into 1 liter of LB medium with the corresponding antibiotic. Shake it at 37 °C until the measured absorbance at 600 nm (A 600 ) is 0.4-0.6 (~3 h). Reserve a 100-µl sample of the culture as the preinduction control for testing sortase expression.
5| Induce protein expression. Add Isopropyl-β-d-thiogalactopyranoside to a final concentration of 0.5 mM and shake it at 25 °C for 16 h.
6| Collection of bacteria.
Reserve a 100-µl sample of the culture as the postinduction control for testing sortase expression.
Centrifuge the culture at 6,000g for 15 min at 4 °C. Decant the supernatant. Resuspend the pellet in 50 ml of nickel-binding buffer, transfer it to a 50-ml centrifuge tube using a motorized pipette and centrifuge the pellet again.
? trouBlesHootInG  pause poInt The pellet can be frozen at −80 °C and processed when convenient. We advise analyzing the pre-and post-induction samples by SDS-PAGE before proceeding to the purification step.
21| Dilute the sortase reaction with nickel-binding buffer to a final volume of 500 µl. (We recommend taking an aliquot of 5 µl from the diluted reaction to later determine the efficiency of purification). Add this to the Ni-NTA resin. Agitate the mixture on an end-over-end shaker for 30 min at 4 °C. These conditions work in most cases. However, keep in mind that the amount of resin to be used per sample depends on the amount of protein that remains unmodified and on the amount of sortase used in the reaction. The protein capacity of the Ni-NTA is ~50 mg ml −1 .
22|
Centrifuge the mixture at 280g for 5 min at 4 °C. Retain the supernatant.
23|
Add 500 µl of nickel-binding buffer to the resin and agitate it on an end-over-end shaker for 10 min at 4 °C.
24|
Centrifuge the mixture at 280g for 5 min at 4 °C. Retain the supernatant. 
25|
• tIMInG
Step 1A, synthesis of GGGK-biotin and GGGK-TAMRA peptides: 2-3 d
Step 1B, synthesis of GGGK-NHS ester probes: 3 d
Step A full sortase reaction often yields a reaction product of mobility distinct from that of the input substrate and the hydrolysis product. The ability to distinguish the various intermediates critically depends on the molecular weight of the anticipated products and the gel systems used to analyze them. For most proteins, >95% and >50% labeling efficiency is achieved when using a peptide or polypeptide-based nucleophile, respectively. The exact reaction conditions for protein labeling need to be determined empirically for each The N and C termini of the protein are in close proximity and the N-terminal amino acid of the protein (glycine or alanine) acts as a nucleophile
Confirm that the first amino acid in the protein of interest is not a glycine or alanine. If it is, mutate it to serine, for example If the first amino acid has to be a glycine or an alanine, design a thrombin cleavage site (LVPR) immediately upstream the first amino acid and proceed to digestion with thrombin upon sortase labeling, to expose the glycine or alanine residues. It is possible that a lysine residue close to the N terminus can serve as the incoming nucleophile for circularization. Consider this possibility if replacement of N-terminal glycine or alanine fails to suppress circularization
No labeling when attempting modification at an internal site even when the site is nicked by a protease
The region is not flexible or accessible
Extend the sequence of the protein by a few amino acids. The number of amino acids required must be determined empirically protein substrate. The range provided has yielded acceptable results in the majority of cases. To achieve maximal levels of labeling, it is helpful to titrate the sortase, substrate and probe concentrations relative to one another, as well as to vary the time of labeling and the temperature of the reaction. Figure 4 | Site-specific installation of ubiquitin in the loop A of cholera toxin using the Ca 2+ -dependent S. aureus sortase A. The sortaggable holotoxin was incubated with trypsin to expose the LPETG motif installed in the CTA1 subunit of cholera toxin. Upon incubation with sortase and the nucleophile ubiquitin (comprising a single glycine residue at its N terminus (GUbq)), we infer that most of the CTA1(>90%) is converted to CTA1-GUbq. In our hands, these yields are typical for sortase-mediated transacylations. Note that CTA1-GUbq is detected only when the three reaction components are mixed. The acyl-intermediate conjugate and the product of CTA1 hydrolysis are also highlighted. In addition, although the subunit B of cholera toxin (CTB) is visible, only the subunit CTA1 participates in the reaction. This attests to the specificity of the sortase-labeling reaction even in protein mixtures. A reducing SDS-PAGE gel stained with Coomassie blue is shown. Lane MW shows molecular-weight markers. See ref. 
